DFTX Definium Therapeutics, Inc.
P/E
--
Forward P/E
--
Price/Sales
--
Beta
2.258
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🟢 Definium Therapeutics, Inc. up 5% as investors anticipate key Phase 3 data
Definium Therapeutics, Inc. is trading at $24.78 (+5.04%) as investor anticipation builds ahead of key clinical trial results and following a positive...
🔴 Definium Therapeutics, Inc. is trading 6% down today as selling pressure persists following its Q1 2026 earnings miss
Definium Therapeutics, Inc. is trading 6% down at $22.61 as selling pressure persists following its recent Q1 2026 earnings miss and soft investor reaction. •...
🔴 Definium Therapeutics, Inc. is trading 6% down today as post-earnings weakness persists
Definium Therapeutics, Inc. is trading 6% down at $22.61 as the stock continues to face pressure following its Q1 2026 earnings disappointment. • The...
🔴 Definium Therapeutics, Inc. is trading 6.11% down
DFTX is trading at $22.59, down 6.11%.
🔴 Definium Therapeutics, Inc. is trading 4.8% down today as post-earnings weakness continues
Definium Therapeutics, Inc. is trading 4.8% down at $22.91, extending its decline following a disappointing Q1 2026 earnings report. • The company recently...